We are a national coalition of AIDS activists -- many living with HIV/AIDS -- working together to end the AIDS epidemic by advancing research on HIV

Drug Development Committee

ATAC's Drug Development Committee (DDC) works with government, academia and the pharmaceutical industry to provide a community perspective into the development of new HIV drugs and the utilization of HIV therapies.

Co-Chairs:

Bob Huff and Michael Dorosh

  Vice Co-Chairs:  

Kevin Fisher and Fred Schaich

*****

DDC Representative to the Board of Directors

Jeff Taylor

To become a DDC member, you must apply to ATAC and be accepted as an ATAC member. Please note: to apply for DDC membership, you will be asked to answer questions related to financial disclosure of any income received from the pharmaceutical industry.

  

• Gilead Sciences 
• ViiV Healthcare 
• Merck & Co.
• Janssen Pharmaceuticals

---

Information Resources:

AIDS/HIV Glossary of Terms from the U.S. National Institutes of Health

AIDSinfo Drugs Database fact sheets on HIV-related drugs

Clinical Trials for HIV/AIDS Drugs from ClinicalTrials.gov